Qingkailing injection induces pseudo-allergic reactions via the MRGPRX2 pathway.

IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
American journal of translational research Pub Date : 2025-03-15 eCollection Date: 2025-01-01 DOI:10.62347/MFBU4210
Yu Zhang, Fang-Mei Liu, Cun-Yu Li, Xue-Jiao Leng, Yun-Feng Zheng, Guo-Ping Peng
{"title":"Qingkailing injection induces pseudo-allergic reactions via the MRGPRX2 pathway.","authors":"Yu Zhang, Fang-Mei Liu, Cun-Yu Li, Xue-Jiao Leng, Yun-Feng Zheng, Guo-Ping Peng","doi":"10.62347/MFBU4210","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Qingkailing Injection (QKLI) is a traditional Chinese medicine injection mainly used for sedation, heat clearing, and other treatments. However, recent clinical studies have shown a risk of pseudo-allergic reactions. The purpose of this study is to elucidate the underlying mechanism of QKLI-induced mast cell degranulation in Laboratory of Allergic Diseases 2 (LAD2) and to validate QKLI-induced activation of guinea pig IgE-independent allergic responses.</p><p><strong>Methods: </strong>Levels of β-hexosaminidase (β-Hex), histamine (His), and complement pathway-related indicators in guinea pigs and LAD2 cells were assayed using the Enzyme-linked Immunosorbent Assay (ELISA). The release rates of β-Hex and His from LAD2 cells were measured using the o-phthalaldehyde (OPA) fluorimetric method. The antagonist for complement component 3a (C3a) receptors, SB290157 and siRNAs were used to inhibit the C3a pathway and the Mas-related G-protein-coupled receptor X2 (MRGPRX2) pathway. The MRGPRX2 pathway and its downstream proteins were detected by Western Blot (WB).</p><p><strong>Results: </strong>The results show that QKLI significantly increased levels of β-Hex, His, C3a, complement component 5a (C5a), and terminal complement complex C5b-9 (SC5b-9) in guinea pigs, while levels of interleukin 4 (IL-4), interleukin 13 (IL-13), and interleukin 6 (IL-6) were unaffected. The C3a receptor inhibitor SB290157 significantly reduced levels of β-Hex and His. In LAD2 cells, QKLI increased the release rates of β-Hex and His in a time-dependent manner and decreased the phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) proteins downstream of the MRGPRX2 pathway. The effective components of QKL, baicalin (BA) and geniposide (GE), individually enhance the allergic responses of LAD2 cells to some extent. However, the use of QKL is significantly superior to the individual use of its components.</p><p><strong>Conclusions: </strong>We found that QKLI induced pseudoanaphylaxis via an IgE-independent response in guinea pigs and through the MRGPRX2 pathway in human LAD2 cells. Among these, the main ingredients causing pseudoallergic reactions in QKLI were BA and GE. Our research contributes to a better understanding of the mechanisms underlying drug hypersensitivity reactions (DHRs).</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 3","pages":"2178-2187"},"PeriodicalIF":1.7000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11982860/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of translational research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/MFBU4210","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Qingkailing Injection (QKLI) is a traditional Chinese medicine injection mainly used for sedation, heat clearing, and other treatments. However, recent clinical studies have shown a risk of pseudo-allergic reactions. The purpose of this study is to elucidate the underlying mechanism of QKLI-induced mast cell degranulation in Laboratory of Allergic Diseases 2 (LAD2) and to validate QKLI-induced activation of guinea pig IgE-independent allergic responses.

Methods: Levels of β-hexosaminidase (β-Hex), histamine (His), and complement pathway-related indicators in guinea pigs and LAD2 cells were assayed using the Enzyme-linked Immunosorbent Assay (ELISA). The release rates of β-Hex and His from LAD2 cells were measured using the o-phthalaldehyde (OPA) fluorimetric method. The antagonist for complement component 3a (C3a) receptors, SB290157 and siRNAs were used to inhibit the C3a pathway and the Mas-related G-protein-coupled receptor X2 (MRGPRX2) pathway. The MRGPRX2 pathway and its downstream proteins were detected by Western Blot (WB).

Results: The results show that QKLI significantly increased levels of β-Hex, His, C3a, complement component 5a (C5a), and terminal complement complex C5b-9 (SC5b-9) in guinea pigs, while levels of interleukin 4 (IL-4), interleukin 13 (IL-13), and interleukin 6 (IL-6) were unaffected. The C3a receptor inhibitor SB290157 significantly reduced levels of β-Hex and His. In LAD2 cells, QKLI increased the release rates of β-Hex and His in a time-dependent manner and decreased the phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) proteins downstream of the MRGPRX2 pathway. The effective components of QKL, baicalin (BA) and geniposide (GE), individually enhance the allergic responses of LAD2 cells to some extent. However, the use of QKL is significantly superior to the individual use of its components.

Conclusions: We found that QKLI induced pseudoanaphylaxis via an IgE-independent response in guinea pigs and through the MRGPRX2 pathway in human LAD2 cells. Among these, the main ingredients causing pseudoallergic reactions in QKLI were BA and GE. Our research contributes to a better understanding of the mechanisms underlying drug hypersensitivity reactions (DHRs).

清开灵注射液通过MRGPRX2通路诱导假过敏反应。
目的:清开灵注射液是一种主要用于镇静、清热等治疗的中药注射剂。然而,最近的临床研究表明,假性过敏反应的风险。本研究的目的是阐明qkli诱导的过敏性疾病实验室2 (LAD2)肥大细胞脱颗粒的潜在机制,并验证qkli诱导的豚鼠ige非依赖性过敏反应的激活。方法:采用酶联免疫吸附法(ELISA)检测豚鼠和LAD2细胞中β-己糖氨酸酶(β-Hex)、组胺(His)和补体途径相关指标的水平。用邻苯二醛(OPA)荧光法测定LAD2细胞中β-Hex和His的释放率。利用补体成分3a (C3a)受体拮抗剂、SB290157和sirna抑制C3a途径和mas相关g蛋白偶联受体X2 (MRGPRX2)途径。Western Blot检测MRGPRX2通路及其下游蛋白表达。结果:结果显示,QKLI显著提高豚鼠β-Hex、His、C3a、补体成分5a (C5a)和末端补体复合物C5b-9 (SC5b-9)水平,而白细胞介素4 (IL-4)、白细胞介素13 (IL-13)和白细胞介素6 (IL-6)水平未受影响。C3a受体抑制剂SB290157显著降低β-Hex和His水平。在LAD2细胞中,QKLI以时间依赖性的方式增加β-Hex和His的释放率,并降低MRGPRX2途径下游的细胞外信号调节激酶1/2 (ERK1/2)蛋白的磷酸化。黄芩苷(baicalin, BA)和京尼平苷(geniposide, GE)的有效成分均在一定程度上增强LAD2细胞的过敏反应。然而,使用QKL明显优于单独使用其组件。结论:我们发现QKLI在豚鼠中通过ige非依赖性反应诱导假过敏反应,在人LAD2细胞中通过MRGPRX2途径诱导假过敏反应。其中,引起QKLI假过敏反应的主要成分为BA和GE。我们的研究有助于更好地理解药物超敏反应(DHRs)的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of translational research
American journal of translational research ONCOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
自引率
0.00%
发文量
552
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信